Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Eli Lilly and Co LLY

Healthcare

Eli Lilly and Company is a medicine company. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant... see more

Add To Watchlist

Bullboard (NYSE:LLY)

View:

(0)
•••

Post by PressReleaseon Aug 27, 2024 6:45am

New Press Release - Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity

Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesityINDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5...read article.

(0)
•••

Post by PressReleaseon Aug 22, 2024 10:01am

New Press Release - Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare Conference

INDIANAPOLIS, Aug. 22, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley 22nd Annual Global Healthcare Conference on Sept. 5, 2024. Jacob Van Naarden, executive vice president and president, Lilly Oncology, will participate in a fireside chat at 7:45 a.m...read article.

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Post by whytestockson Aug 20, 2024 5:00pm

Why Eli Lilly Topped the Market on Tuesday

NEWS: $LLY Why Eli Lilly Topped the Market on Tuesday2024-08-20 16:46:42 ET The U.S. pharmaceutical stock of the moment, Eli Lilly (NYSE: LLY) , did rather well on Tuesday. Its price closed the day ...more

(0)
•••

Post by PressReleaseon Aug 20, 2024 6:45am

New Press Release - Tirzepatide reduced the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight

176-week SURMOUNT-1 Phase 3 study in adults with pre-diabetes is the longest completed trial of tirzepatide to date Tirzepatide resulted in sustained weight loss through the treatment period, averaging a 22.9% decrease in body weight with the 15 mg dose at end of treatmentResults are consistent...read article.

(0)
•••

Post by PressReleaseon Aug 16, 2024 4:15pm

New Press Release - Lilly announces retirement of Marschall S. Runge from its Board of Directors

INDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D., Ph.D. is retiring from his role as an independent director of Lilly's board of directors effective Aug. 31, 2024.Dr. Runge has served on Lilly's board since 2013, including...read article.

(0)
•••

Post by PressReleaseon Aug 16, 2024 8:40am

New Press Release - Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease

Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field of gastroenterologyINDIANAPOLIS, Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY...read article.

(0)
•••

Post by PressReleaseon Aug 13, 2024 8:00am

New Press Release - Lilly opens state-of-the-art research and development center in the Boston Seaport

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway LabsNew 346,000 square foot facility will accommodate approximately 500 Lilly scientists and researchers, in addition to 200 people from Lilly...read article.

Post by whytestockson Aug 09, 2024 2:16pm

Prediction: This Weight Loss Stock Will Be Acquired Within t

JUST IN: $LLY Prediction: This Weight Loss Stock Will Be Acquired Within the Next Year2024-08-09 08:46:00 ET One of the biggest movements in the pharmaceutical industry right now is developing ...more

Post by whytestockson Aug 09, 2024 2:00pm

2 Healthcare Stocks to Buy Hand Over Fist in August

JUST IN: $LLY 2 Healthcare Stocks to Buy Hand Over Fist in August2024-08-09 06:02:00 ET The healthcare sector is home to many prominent corporations. Few are more famous or recognizable than Eli Lilly ...more

Post by E30S14on Aug 08, 2024 2:48pm

Monster

Eli Lilly and Company is a monster. $844.16 72.015 | 9.33% Bid: 843.34 x 400 Ask: 844.97 x 300 Volume: 6,229,157 USD ...more

Post by whytestockson Jul 27, 2024 7:31am

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Just In: $LLY Bull Market Buys: 2 Growth Stocks to Own for the Long Run2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently ...more

Post by whytestockson Jul 18, 2024 5:46am

Will Eli Lilly Do a Stock Split in 2024?

News; $LLY Will Eli Lilly Do a Stock Split in 2024?2024-07-18 05:23:00 ET Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the ...more

117